Retailers have been sweet on the chocolate category, but non-chocolate sales also have been strong. The National Confectioners Association forecasts that while chocolate sales were ahead 4% last year, with $4 billion growth over the next five years, a number of non-chocolate candy segments also had a boost.
With Pfizer's targeted takeover of AstraZeneca, there's been much talk about inversion, or the practice of re-domiciling a company's headquarters to another country in an effort to save on corporate taxes.
A new report by Milliman released Thursday found that Silver plans with combined deductibles offered through the Health Insurance Exchanges may require patients to pay more than twice as much out of pocket for prescription medicines overall as they would under a typical employer plan.
Skin care oils. It’s a trend that isn’t showing signs of slowing as women increasingly incorporate them into their beauty regimens, and manufacturers continue to heed the call with new innovations hitting shelves.
Mars Chocolate North America is launching a number of treats for Halloween 2014. The Halloween chocolate category exceeded $1 billion in sales for the first time in 2013, with an increase of 6.4% over the previous year, according to Mars.
Teva Pharmaceutical was denied in its suit to block approval of Mylan's and Sandoz' generic Copaxone, a multiple sclerosis, drug 10 days before the patent on the medication expires, according to a Bloomberg report published Thursday morning.
Walmart continues to envision flat same-store sales at its U.S. stores after reporting weaker than expected profits on weak U.S. sales results that were negatively affected by a winter that wouldn’t end.
Actavis on Tuesday announced that it has received final approval from the Food and Drug Administration on its abbreviated new drug application for a generic version of Mallinckrodt's Exalgo (hydromorphone hydrochloride extended-release tablets 8 mg, 12 mg and 16 mg).
Actavis on Wednesday announced the proposed senior management team that will lead the specialty pharmaceutical company pending the successful close of the acquisition of Forest Labs, which is anticipated at mid-year.
About half of all Americans reported taking one or more prescription drugs in the past 30 days during 2007-2010, and 1-in-10 took five or more, according to "Health, United States, 2013," the government’s annual, comprehensive report on the nation’s health that was released Wednesday.
Authentic. Cause-related. Good for you. That’s what many of today’s shoppers — especially the 77 million millennials throughout the country — want in the products they buy, and beauty is no exception. This has given rise to an array of beauty brands that promise to do much more than enhance one’s physical appearance.
Dr. Reddy's Labs has named Satish Reddy as chairman of the board. Reddy previously held the position of vice-chairman, managing director and COO. GV Prasad will continue to serve as CEO and provide leadership to the company in an executive capacity.